Argos Therapeutics Inc. | Ownership
Companies that own Argos Therapeutics Inc.
Wedbush Securities, Inc. (Investment Management)
78,000
0.74%
35,000
0%
06/30/2018
Meeder Asset Management, Inc.
5,671
0.05%
358
0%
06/29/2018
Invesco Capital Management LLC
2,553
0.02%
0
0%
09/05/2018
Securities America Advisors, Inc.
128
0%
0
0%
06/30/2018
RBC Capital Markets LLC (Investment Management)
0
0%
-39
0%
06/30/2018
RBC Dominion Securities, Inc.
0
0%
-27
0%
06/30/2018
Wasatch Advisors, Inc.
0
0%
-25,679
0%
03/31/2018
UBS Securities LLC
0
0%
-9,354
0%
06/30/2018
Gryphon Financial Partners LLC
0
0%
-50
0%
06/30/2018
| Address |
4233 Technology Drive
Durham North Carolina 27704
United States
|
|
Employees
|
- |
| Website |
http://www.argostherapeutics.com |
| Updated |
09/14/2018 |
| Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC. |
